AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 48 filers reported holding AYTU BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $58,000 | -40.2% | 53,530 | -25.3% | 0.00% | -66.7% |
Q4 2021 | $97,000 | -58.4% | 71,625 | -11.4% | 0.00% | -25.0% |
Q3 2021 | $233,000 | -15.3% | 80,864 | +47.5% | 0.00% | -20.0% |
Q2 2021 | $275,000 | -11.9% | 54,819 | +33.7% | 0.01% | 0.0% |
Q1 2021 | $312,000 | – | 41,007 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,398,776 | $8,365,000 | 6.40% |
ARMISTICE CAPITAL, LLC | 1,333,334 | $7,973,000 | 0.27% |
PIPER SANDLER & CO. | 49,590 | $297,000 | 0.21% |
SEARLE & CO. | 14,000 | $84,000 | 0.04% |
WINTON GROUP Ltd | 28,653 | $171,000 | 0.01% |
Squarepoint Ops LLC | 34,862 | $208,000 | 0.00% |
BELLEVUE ASSET MANAGEMENT, LLC | 260 | $2,000 | 0.00% |
Clearstead Advisors, LLC | 1,421 | $8,000 | 0.00% |
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 889 | $5,000 | 0.00% |
Ameritas Investment Partners, Inc. | 202 | $1,000 | 0.00% |